NFKB1 and eosinophilia-myalgia syndrome: Phosphorylation, which inhibits the activation of MEK/ERK, further blocks the transcriptional activation of its downstream effector NF-κB protein and effectively inhibits the growth, proliferation, migration, and invasion of the ectopic lesions of EMs.